http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107281209-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate | 2017-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107281209-B |
| titleOfInvention | A kind of pharmaceutical composition of anti-gastric-ulcer and preparation method thereof and purposes |
| abstract | Present invention relates particularly to pharmaceutical composition of a kind of anti-gastric-ulcer and preparation method thereof and purposes.The pharmaceutical composition, including following raw material: 50~59 parts by weight of liquiritin, 170~185 parts by weight of enoxolone, 180~200 parts by weight of saikosaponin C.Pharmaceutical composition of the present invention, selecting liquiritin, enoxolone and saikosaponin C is raw material, and each raw material mutual cooperation, collective effect under specific proportion has the function of significant anti-gastric-ulcer；The pharmaceutical composition is to the therapeutic effect of gastric ulcer better than any two kinds of therapeutic effects to gastric ulcer in three kinds of raw materials, and for also superior to three kinds raw materials individually to the therapeutic effect of gastric ulcer, which has the function of synergy. |
| priorityDate | 2017-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.